Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 2, 2026

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform
05:51

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform

Published on: May 3, 2024

Large-scale recombinant adeno-associated virus production.

Robert M Kotin1

  • 1Laboratory of Molecular Virology and Gene Therapy, Center for Developmental Biology and Genetics, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. kotinr@nhlbi.nih.gov

Human Molecular Genetics
|May 3, 2011
PubMed
Summary

Scalable production of recombinant adeno-associated virus (rAAV) vectors remains challenging. Suspension cell cultures using baculovirus expression offer a more scalable and economical platform than adherent mammalian cells for robust rAAV manufacturing.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of evolutionarily conserved viral integration sites as safe harbors for human gene therapy.

iScience·2025
Same author

Selective Enrichment of Full Capsids of Adeno-Associated Virus.

ACS nano·2025
Same author

An Integrated Experimental and Modeling Approach for Crystallization of Complex Biotherapeutics.

Crystal growth & design·2025
Same author

Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system.

Molecular therapy. Methods & clinical development·2023
Same author

Comparative analysis reveals the long-term coevolutionary history of parvoviruses and vertebrates.

PLoS biology·2022
Same author

Evolution of dependoparvoviruses across geological timescales-implications for design of AAV-based gene therapy vectors.

Virus evolution·2020

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy Manufacturing

Background:

  • Recombinant adeno-associated virus (rAAV) is a key vector for gene therapy, but scalable and economical production remains a significant hurdle.
  • Previous reports on improving rAAV production have often fallen short of enabling robust manufacturing for research and clinical applications.

Purpose of the Study:

  • To compare and discuss two prominent rAAV production platforms: adherent mammalian cells and suspension invertebrate cells.
  • To highlight the advantages of suspension cell culture systems for scalable and automated rAAV manufacturing.

Main Methods:

  • Adherent mammalian cell platform utilizing chemical transient transfection for gene delivery.
  • Suspension invertebrate cell platform employing baculovirus expression vectors for gene delivery and helper functions.

More Related Videos

Production of High-Yield Adeno Associated Vector Batches Using HEK293 Suspension Cells
08:17

Production of High-Yield Adeno Associated Vector Batches Using HEK293 Suspension Cells

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jun 2, 2026

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform
05:51

A Streamlined and Standardized Procedure for Generating High-Titer, High-Quality Adeno-Associated Virus Vectors Utilizing a Cell Factory Platform

Published on: May 3, 2024

Production of High-Yield Adeno Associated Vector Batches Using HEK293 Suspension Cells
08:17

Production of High-Yield Adeno Associated Vector Batches Using HEK293 Suspension Cells

Published on: April 26, 2024

  • Comparison of scalability, automation potential, and process control between the two platforms.

    • Main Results:

    • Suspension cell cultures demonstrate intrinsically greater scalability compared to adherent cell cultures for rAAV production.
    • Baculovirus expression systems efficiently provide necessary helper functions for rAAV DNA replication within suspension cells.
    • Upstream processes for suspension cultures are amenable to automation, monitoring, and regulation for consistent yields.

    Conclusions:

    • The suspension invertebrate cell culture platform, utilizing baculovirus, presents a more scalable and potentially economical approach to rAAV vector production.
    • Automation and process control in suspension cultures facilitate consistent and high-yield rAAV manufacturing for clinical and research needs.
    • Further development and improvement of rAAV production methods are crucial for advancing gene therapy applications.